NFB-08. PHASE II STUDY OF AXITINIB IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS

INTRODUCTION: Vascular endothelial growth factor receptor (VEGFR), platelet derived growth factor receptor (PDGFR), and c-KIT represent clinically and/or preclinically validated molecular targets in vestibular schwannomas. We conducted a single institution, prospective, open-label, two-stage phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Phadnis, Sheetal, Hagiwara, Mari, Yaffe, Anna, Mitchell, Carole, Nicolaides, Theodore, Akshintala, Srivandana, Hochman, Tsivia, Goldberg, Judith, Allen, Jeffrey, Karajannis, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neurofibromatosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715576/
http://dx.doi.org/10.1093/neuonc/noaa222.612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715576/
http://dx.doi.org/10.1093/neuonc/noaa222.612

Ejemplares similares